Cargando…

PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas

Numerous studies have shown that human papillomavirus (HPV) infection is one of the important risk factors for head and neck squamous cell carcinoma (HNSCC) progression and affects the expression of multiple genes, which might serve as new biomarkers. This study examines the effects of HPV infection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kopczyńska, Magda, Kolenda, Tomasz, Guglas, Kacper, Sobocińska, Joanna, Teresiak, Anna, Bliźniak, Renata, Mackiewicz, Andrzej, Mackiewicz, Jacek, Lamperska, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599931/ https://www.ncbi.nlm.nih.gov/pubmed/32998396 http://dx.doi.org/10.3390/diagnostics10100762

Ejemplares similares

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck
por: Łasińska, Izabela, et al.
Publicado: (2020)

lncRNA Expression after Irradiation and Chemoexposure of HNSCC Cell Lines
por: Guglas, Kacper, et al.
Publicado: (2018)

lncRNA in HNSCC: challenges and potential
por: Guglas, Kacper, et al.
Publicado: (2017)

YRNAs and YRNA-Derived Fragments as New Players in Cancer Research and Their Potential Role in Diagnostics
por: Guglas, Kacper, et al.
Publicado: (2020)

Quantification of long non-coding RNAs using qRT-PCR: comparison of different cDNA synthesis methods and RNA stability
por: Kolenda, Tomasz, et al.
Publicado: (2019)

YRNAs: New Insights and Potential Novel Approach in Head and Neck Squamous Cell Carcinoma
por: Guglas, Kacper, et al.
Publicado: (2020)

The Impact of YRNAs on HNSCC and HPV Infection
por: Guglas, Kacper, et al.
Publicado: (2023)

Diagnostics of Mutations in MMR/EPCAM Genes and Their Role in the Treatment and Care of Patients with Lynch Syndrome
por: Sobocińska, Joanna, et al.
Publicado: (2020)

Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology
por: Kozłowska-Masłoń, Joanna, et al.
Publicado: (2022)

Long Intergenic Non-Coding RNAs in HNSCC: From “Junk DNA” to Important Prognostic Factor
por: Kozłowska, Joanna, et al.
Publicado: (2021)

C10orf55, CASC2, and SFTA1P lncRNAs Are Potential Biomarkers to Assess Radiation Therapy Response in Head and Neck Cancers
por: Paszkowska, Anna, et al.
Publicado: (2022)

Midsize noncoding RNAs in cancers: a new division that clarifies the world of noncoding RNA or an unnecessary chaos?
por: Guglas, Kacper, et al.
Publicado: (2022)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
por: Kozłowska, Joanna, et al.
Publicado: (2020)

The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules?
por: Stasiak, Maciej, et al.
Publicado: (2021)

Host gene and its guest: short story about relation of long-noncoding MIR31HG transcript and microRNA miR-31
por: Kolenda, Tomasz, et al.
Publicado: (2023)

The mystery of let-7d – a small RNA with great power
por: Kolenda, Tomasz, et al.
Publicado: (2014)

Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
por: Sobocińska, Joanna, et al.
Publicado: (2022)

The Oncogenic Roles of PTTG1 and PTTG2 Genes and Pseudogene PTTG3P in Head and Neck Squamous Cell Carcinomas
por: Grzechowiak, Inga, et al.
Publicado: (2020)

2D and 3D cell cultures – a comparison of different types of cancer cell cultures
por: Kapałczyńska, Marta, et al.
Publicado: (2016)

Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics
por: Lamperska, Katarzyna Monika, et al.
Publicado: (2017)

Biological role and diagnostic utility of ribosomal protein L23a pseudogene 53 in cutaneous melanoma
por: Kolenda, Tomasz, et al.
Publicado: (2023)

The Landscape of Transmembrane Protein Family Members in Head and Neck Cancers: Their Biological Role and Diagnostic Utility
por: Koteluk, Oliwia, et al.
Publicado: (2021)

Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients
por: Przybyła, Anna, et al.
Publicado: (2015)

Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results
por: Mackiewicz, Jacek, et al.
Publicado: (2018)

Prins and C-PRINS: Promising tools for the physical mapping of the lupin genome
por: Kaczmarek, Anna, et al.
Publicado: (2006)

Recent advances in melanoma treatment – American Society of Clinical Oncology (ASCO) 2012 perspective
por: Mackiewicz, Jacek, et al.
Publicado: (2012)

BRAF and MEK inhibitors in the era of immunotherapy in melanoma patients
por: Mackiewicz, Jacek, et al.
Publicado: (2018)

Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma
por: Mackiewicz, Jacek, et al.
Publicado: (2017)

RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1α and LncRNA PRINS
por: Yu, Tung-Min, et al.
Publicado: (2016)

The lncRNA PRINS-miRNA-mRNA Axis Gene Expression Profile as a Circulating Biomarker Panel in Psoriasis
por: Abdallah, Hoda Y., et al.
Publicado: (2022)

Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population
por: Mackiewicz-Wysocka, Małgorzata, et al.
Publicado: (2017)

LATS1 Is a Mediator of Melanogenesis in Response to Oxidative Stress and Regulator of Melanoma Growth
por: Kazimierczak, Urszula, et al.
Publicado: (2021)

Recent Advances in the Prins Reaction
por: Reyes, Efraim, et al.
Publicado: (2022)

Angiotensin-converting enzyme inhibitors for ovarian cancer? — a new adjuvant option or a silent trap
por: Regulska, Katarzyna, et al.
Publicado: (2023)

A new intermediate in the Prins reaction
por: Yamabe, Shinichi, et al.
Publicado: (2013)

The Catalytic Asymmetric Intermolecular Prins Reaction
por: Díaz-Oviedo, C. David, et al.
Publicado: (2021)

PRIN: a predicted rice interactome network
por: Gu, Haibin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fpbenlololdpd7dce7ghovg2t9